Research progress and challenges to coronavirus vaccine development-Reference-Cited by-同舟云学术

Research progress and challenges to coronavirus vaccine development

Published:2020-10-07 Issue:2 Volume:93 Page:741-754
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Zhou Peiwen¹^ORCID,Li Zonghui²^ORCID,Xie Linqing³^ORCID,An Dong⁴^ORCID,Fan Yaohua²^ORCID,Wang Xiao²^ORCID,Li Yiwei²^ORCID,Liu Xiaohong²^ORCID,Wu Jianguo¹²^ORCID,Li Geng¹²^ORCID,Li Qin³^ORCID

Affiliation:

1. Department of Guangdong Provincial Key Laboratory of Virology, Institute of Medical Microbiology Jinan University Guangzhou China

2. Department of Laboratory Animal Center Guangzhou University of Chinese Medicine Guangzhou China

3. Department of Guangzhou Cyanvaccine Biotechnology Co, Ltd Guangzhou China

4. Department of Infectious Diseases, College of Veterinary Medicine University of Georgia Athens Georgia USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26517

Reference97 articles.

1. World Health Organization. Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection [published online ahead of print January 21 2020].

2. World Health Organization. Novel Coronavirus (2019‐nCoV) situation report‐190 [published online ahead of print July 28 2020].

3. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

4. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003

5. http://www.who.int/csr/sars/country/table20040421/en/index.html

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen;Human Vaccines & Immunotherapeutics;2024-05-17

2. Towards a Safer Future: Enhancing Vaccine Development to Combat Animal Coronaviruses;Vaccines;2024-03-19

3. Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection;Biologicals;2023-05

4. Perspective Chapter: Tracking Trails of SARS CoV-2 – Variants to Therapy;Infectious Diseases;2023-03-29

5. Coronavirus Pandemics;2000 Years of Pandemics;2023